Neuronal nAChR stereoselectivity to non-natural epibatidine derivatives

FEBS Letters

Volumn 450, Issue 3, 1999, Pages 273-279

  Bertrand, Sonia ^a   Patt, Jörg T ^b   Spang, Jörg E ^b   Westera, Gerrit ^b   Schubiger, P August ^b   Bertrand, Daniel ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Brain; Epibatidine; Imaging; Nicotinic acetylcholine receptor; Pharmacophore

Indexed keywords

EPIBATIDINE; NICOTINIC RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG LABELING; DRUG SYNTHESIS; ELECTROPHYSIOLOGY; ENANTIOMER; IMAGING; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHYLATION; MOUSE; NONHUMAN; OOCYTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION; XENOPUS;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; GANGLIA; MALE; NEURONS; NICOTINIC AGONISTS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; TOMOGRAPHY, EMISSION-COMPUTED; XENOPUS;

ANURA;

EID: 0032940621     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(99)00473-1     Document Type: Article

References (29)

1. Langley J.N. J. Physiol. 33:1905;374-413.
2. Ascher P., Large W.A., Rang H.P. J. Physiol. 295:1979;139-170.
3. Benowitz N.L. Annu. Rev. Pharmacol. Toxicol. 36:1996;597-613.
4. Corrigall W.A., Coen K.M., Adamson K.L. Brain Res. 653:1994;278-284.
5. Cimino M., Marini P., Colombo S., Andena M., Cattabeni F., Fornasari D., Clementi F. J. Neural Transm. Gen. Sect. 100:1995;77-92.
6. Deltoro E.D., Juiz J.M., Smillie F.I., Lindstrom J., Criado M. Dev. Brain Res. 98:1997;125-133.
7. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. J. Comp. Neurol. 284:1989;314-335.
8. Nitta A., Katono Y., Itoh A., Hasegawa T., Nabeshima T. Pharmacol. Biochem. Behav. 49:1994;807-812.
9. Balfour D.J. Addiction. 89:1994;1419-1423.
10. Zoli M., Le N.N., Hill J.J., Changeux J.P. J. Neurosci. 15:1995;192-1939.
11. Nyback H., Halldin C., Ahlin A., Curvall M., Eriksson L. Psychopharmacology (Berl.). 115:1994;31-36.
12. Muric R.F., Berridge M.S., Friedland R.P., Zhu N., Nelson A.D. J. Nucl. Med. 39:1998;2048-2054.
13. Patt J.T., Westera G., Buch A., Fletcher S.R., Schubiger P.A. J. Lab. Comp. Radiopharm. 17:1995;355-356.
14. Villemagne V.L., et al. J. Nucl. Med. 38:1997;1737-1741.
15. Musachio J.L., Villemagne V.L., Scheffel U., Stathis M., Finley P., Horti A., London E.D., Dannals R.F. Synapse. 26:1997;392-399.
16. Horti A.G., et al. J. Med. Chem. 41:1998;4199-4206.
17. Kassiou M., Scheffel U.A>, Ravert H.T., Mathews, W.B., Musachio J.L., London E.D., Dannals R.F. Life Sci. 63:1998;L13-18.
18. Patt, J.T., Spang, J.E., Westera, G., Buck, A. and Schubiger, P.A. (1999) Nucl. Med. Biol. (in press).
19. Bertrand D., Cooper E., Valera S., Rungger D., Ballivet M. Methods Neurosci. 4:1991;174-193.
20. Bertrand D., Changeux J.P. Semin. Neurosci. 7:1995;75-90.
21. Boyd R.T., Jacob M.H., McEachern A.E., Caron S., Berg D.K. J. Neurobiol. 22:1991;1-14.
22. Conroy W.G., Berg D.K. J. Biol. Chem. 270:1995;4424-4431.
23. Séguéla P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. J. Neurosci. 13:1993;596-604.
24. Alkondon M., Albuquerque E.X. J. Pharmacol. Exp. Ther. 274:1995;771-782.
25. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Mol. Pharmacol. 48:1995;774-782.
26. Couturier S., et al. Neuron. 5:1990;847-856.
27. Gopalakrishnan M., et al. Eur. J. Pharmacol. Mol. Pharmacol. 290:1995;237-246.
28. Scheffel U., Taylor G.F., Kepler J.A., Carroll F.I., Kuhar M.J. NeuroReport. 6:1995;2483-2488.
29. Ding Y.S., Molina P.E., Fowler J.S., Logan J., Volkow N.D., Kuhar M.J., Caroll F.I. Nucl. Med. Biol. 26:1999;139-148.